MedinCell S.A.
MEDCL.PA · PAR
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | €419,056 | €277,090 | €247,099 | €184,501 |
| - Cash | €59,040 | €19,460 | €6,467 | €24,617 |
| + Debt | €58,756 | €58,961 | €57,708 | €47,492 |
| Enterprise Value | €418,772 | €316,591 | €298,340 | €207,376 |
| Revenue | €25,541 | €9,160 | €9,944 | €4,090 |
| % Growth | 178.8% | -7.9% | 143.1% | – |
| Gross Profit | €25,541 | €9,160 | €9,944 | €4,090 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -€11,200 | -€18,614 | -€26,413 | -€21,446 |
| % Margin | -43.9% | -203.2% | -265.6% | -524.4% |
| Net Income | -€18,438 | -€25,038 | -€32,010 | -€24,806 |
| % Margin | -72.2% | -273.3% | -321.9% | -606.5% |
| EPS Diluted | -0.63 | -0.88 | -1.27 | -1 |
| % Growth | 28.4% | 30.7% | -27% | – |
| Operating Cash Flow | €19,465 | -€11,922 | -€21,005 | -€21,362 |
| Capital Expenditures | -€1,660 | -€1,191 | -€1,027 | -€1,974 |
| Free Cash Flow | €17,805 | -€13,113 | -€22,032 | -€23,336 |